
Adorbis2.5 mg
Ziska Pharmaceuticals Ltd.
Bisoprolol Hemifumarate is a cardioselective (beta-1 selective) beta-adrenergic blocking agent with the following indications: Established/Approved Uses Hypertension: Indicated alone or in…
Bisoprolol Hemifumarate is a cardioselective (beta-1 selective) beta-adrenergic blocking agent with the following indications:
Note: Bisoprolol Hemifumarate should always be used as prescribed by a physician; the indication, dose, and monitoring plan depend on the individual patient's cardiac status.
Initial dose: 5 mg once daily. May be increased to 10 mg once daily, and up to a maximum of 20 mg once daily, if needed, based on blood pressure response. In patients with renal or hepatic impairment, initiate at 2.5 mg once daily.
Initial dose: 5 mg once daily, titrated according to response, up to a maximum of 20 mg once daily.
Must only be initiated in stable patients by a physician experienced in heart failure management, following a strict up-titration schedule:
| Step | Dose | Duration before next increase |
|---|---|---|
| 1 | 1.25 mg once daily | At least 1 week (if tolerated) |
| 2 | 2.5 mg once daily | At least 1 week |
| 3 | 3.75 mg once daily | At least 1 week |
| 4 | 5 mg once daily | At least 4 weeks |
| 5 | 7.5 mg once daily | At least 4 weeks |
| 6 | 10 mg once daily (target/maintenance dose) | - |
In patients with severe renal impairment (creatinine clearance below 20 mL/min) or severe hepatic impairment, the maximum recommended dose is generally 10 mg once daily; dose adjustment should be individualized by the physician.
Bisoprolol Hemifumarate should not be discontinued abruptly (see Precautions and Warnings).
Side effects of Bisoprolol Hemifumarate are generally dose-related and most common at the start of treatment or during dose up-titration.
Bisoprolol Hemifumarate is contraindicated in patients with:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.